Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
Public ClinicalTrials.gov record NCT02255656. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Primary Objective: To evaluate long-term safety of alemtuzumab. Secondary Objectives: * To evaluate long term efficacy of alemtuzumab. * To evaluate the safety profile of participants who received other Disease Modifying Treatment (DMT) following alemtuzumab treatment. * To evaluate participant-reported Quality of Life (QoL) outcomes and health resource utilization of participant who received alemtuzumab. * To evaluate as needed re-treatment with alemtuzumab and other DMTs.
Study identification
- NCT ID
- NCT02255656
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 1,062 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 7, 2015 (Actual)
- Primary completion
- Jul 15, 2020 (Actual)
- Completion
- Jul 15, 2020 (Actual)
- Last update posted
- Mar 28, 2022
2015 – 2020
United States locations
- U.S. sites
- 52
- U.S. states
- 25
- U.S. cities
- 50
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number 1086 | Cullman | Alabama | 00000 | — |
| Investigational Site Number 1031 | Phoenix | Arizona | 85013 | — |
| Investigational Site Number 1171 | Phoenix | Arizona | 85018 | — |
| Investigational Site Number 1090 | Tucson | Arizona | 85704 | — |
| Investigational Site Number 1040 | Berkeley | California | 94705 | — |
| Investigational Site Number 1152 | Fullerton | California | 92835 | — |
| Investigational Site Number 1093 | Pasadena | California | 91105 | — |
| Investigational Site Number 1027 | Fort Collins | Colorado | 80528 | — |
| Investigational Site Number 1078 | Jacksonville | Florida | 32209 | — |
| Investigational Site Number 1059 | Maitland | Florida | 32751 | — |
| Investigational Site Number 1173 | Sarasota | Florida | 34239 | — |
| Investigational Site Number 1034 | Sunrise | Florida | 33351 | — |
| Investigational Site Number 1005 | Tampa | Florida | 33609 | — |
| Investigational Site Number 1049 | Tampa | Florida | 33612 | — |
| Investigational Site Number 1008 | Northbrook | Illinois | 60062 | — |
| Investigational Site Number 1001 | Fort Wayne | Indiana | 46845 | — |
| Investigational Site Number 1024 | Indianapolis | Indiana | 46202 | — |
| Investigational Site Number 1017 | Des Moines | Iowa | 50314 | — |
| Investigational Site Number 1022 | Kansas City | Kansas | 66160 | — |
| Investigational Site Number 1083 | Lenexa | Kansas | 66214 | — |
| Investigational Site Number 1039 | Lexington | Kentucky | 40513 | — |
| Investigational Site Number 1021 | Louisville | Kentucky | 40202 | — |
| Investigational Site Number 1061 | Wellesley | Massachusetts | 02481 | — |
| Investigational Site Number 1028 | Worcester | Massachusetts | 01655 | — |
| Investigational Site Number 1025 | Ann Arbor | Michigan | 48105-2945 | — |
| Investigational Site Number 1020 | Detroit | Michigan | 48201 | — |
| Investigational Site Number 1054 | Traverse City | Michigan | 49684 | — |
| Investigational Site Number 1084 | Kansas City | Missouri | 64111 | — |
| Investigational Site Number 1092 | St Louis | Missouri | 63131 | — |
| Investigational Site Number 1073 | Teaneck | New Jersey | 07666 | — |
| Investigational Site Number 1014 | Albuquerque | New Mexico | 87131 | — |
| Investigational Site Number 1081 | Mineola | New York | 11501 | — |
| Investigational Site Number 1026 | New York | New York | 10029 | — |
| Investigational Site Number 1160 | Patchogue | New York | 11772 | — |
| Investigational Site Number 1015 | Rochester | New York | 14642 | — |
| Investigational Site Number 1053 | Syracuse | New York | 13202 | — |
| Investigational Site Number 1095 | Chapel Hill | North Carolina | 27599 | — |
| Investigational Site Number 1082 | Winston-Salem | North Carolina | 27103 | — |
| Investigational Site Number 1035 | Cleveland | Ohio | 44195 | — |
| Investigational Site Number 1058 | Uniontown | Ohio | 44685 | — |
| Investigational Site Number 1067 | Oklahoma City | Oklahoma | 73104 | — |
| Investigational Site Number 1097 | Allentown | Pennsylvania | 18103 | — |
| Investigational Site Number 1057 | Providence | Rhode Island | 02905 | — |
| Investigational Site Number 1163 | Cordova | Tennessee | 38018 | — |
| Investigational Site Number 1055 | Franklin | Tennessee | 37064 | — |
| Investigational Site Number 1009 | Knoxville | Tennessee | 37922 | — |
| Investigational Site Number 1042 | Nashville | Tennessee | 37215 | — |
| Investigational Site Number 1018 | Houston | Texas | 77030 | — |
| Investigational Site Number 1002 | Round Rock | Texas | 78681 | — |
| Investigational Site Number 1046 | San Antonio | Texas | — | — |
| Investigational Site Number 1037 | Vienna | Virginia | 22182 | — |
| Investigational Site Number 1068 | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02255656, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 28, 2022 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02255656 live on ClinicalTrials.gov.